Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Celgene's New Multiple Myeloma Drug Is Beating Amgen
TheStreet.com
Thu, 10/24/13 - 09:59 am
Tags:
Celgene, Multiple Myeloma, Amgen, Kyprolis, Pomalyst
Biotech drugmaker Amgen's 3Q profit jumps 24 percent on stronger sales of most of its drugs
Yahoo/AP
Tue, 10/22/13 - 04:56 pm
Tags:
earnings, Amgen
Amgen acquires Filgrastim franchise rights from Roche
Yahoo/Fly on the Wall
Tue, 10/22/13 - 11:28 am
Tags:
Roch, filgrastim, Amgen, pegfilgrastim
Whisper Number: What Will Amgen’s Shares Do Post-Earnings?
Wall St. Cheat Sheet
Tue, 10/22/13 - 11:24 am
Tags:
Amgen, earnings
Can Amgen Grow Faster Than Gilead Sciences and Teva Pharmaceutical?
Motley Fool
Mon, 10/21/13 - 08:37 am
Tags:
Gilead, Teva, Amgen
3 Things to Watch in Amgen's Earnings Report
Motley Fool
Mon, 10/21/13 - 08:35 am
Tags:
earnings, Amgen
Earnings Preview: Amgen to report 3Q results
Yahoo/AP
Sat, 10/19/13 - 03:54 pm
Tags:
earnings, Amgen
Amgen's 3Q report to focus on cancer drugmaker purchase, testing of its own experimental drugs
Yahoo/AP
Fri, 10/18/13 - 09:31 am
Tags:
Amgen, earnings
Is Amarin's FDA Panel Important for Other Cardiovascular Drugmakers?
Motley Fool
Thu, 10/17/13 - 06:12 pm
Tags:
FDA, Vascepa, Amarin, AstraZeneca, Regeneron, Amgen
AstraZeneca, Amgen Crohn's drug runs into PhII 'logistical' snafu
Fierce Biotech
Thu, 10/17/13 - 10:57 am
Tags:
Amgen, Crohn's Disease, AMG 181, AstraZeneca
BIND Therapeutics Had A Muted IPO But The Thesis Intrigues
Seeking Alpha
Wed, 10/9/13 - 10:11 am
Tags:
Bind Therapeutics, IPOs, AstraZeneca, Amgen, Pfizer
Knockoff Lust: AbbVie's $9 Billion-A-Year Humira
Seeking Alpha
Wed, 10/9/13 - 08:25 am
Tags:
AbbVie, Humira, JNJ, Amgen, rheumatoid arthritis
Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill
Seeking Alpha
Mon, 10/7/13 - 08:48 am
Tags:
Rexahn, chemotherapy, Amgen, Bristol-Myers Squibb, Merck, Novartis, Teva, RX-3117
Amgen announces data from romosozumab, Prolia studies
The Fly on the Wall
Fri, 10/4/13 - 11:17 am
Tags:
Amgen, romosozumab, Prolia, UCB, bone mineral density
New class of psoriasis drugs being developed
Bloomberg
Fri, 10/4/13 - 10:14 am
Tags:
psoriasis, Novartis, AstraZeneca, Amgen, Eli Lilly, Enbrel, secukinumab, brodalumab, IL-17 blockers
Top Biotechs Set to Win in the War on Cancer
Yahoo/Wall St 24-7
Thu, 10/3/13 - 11:57 am
Tags:
biotech, Biomarin, Immunogen, Ariad Pharmaceuticals, Amgen, Celgene, Gilead Sciences
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
Tags:
drug launches, Eylea, Regeneron, Bayer, Tecfidera, Biogen Idec, Kalydeco, Vertex Pharmaceuticals, Kadcyla, Roche, Genentech, Victoza, Novo Nordisk, Gilenya, Novartis, Zytiga, JNJ, Yervoy, Bristol-Myers Squibb, Stribild, Gilead Sciences Xtandi, Medivation, Astellas, Afinitor, Amgen, Prolia, Stelara, Kyprolis, Xarelto, ONYX Pharmaceuticals
Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
Yahoo
Tue, 10/1/13 - 08:50 am
Tags:
Amgen, ONYX Pharmaceuticals, M&A
Amgen's 10 Billion Dollar Molecule
Seeking Alpha
Mon, 09/30/13 - 10:44 am
Tags:
Amgen, Takeda, ONYX Pharmaceuticals, Kyprolis
China Biotech In Review: Amgen Partners With ShanghaiTech On China R&D Center
Seeking Alpha
Sun, 09/29/13 - 01:29 pm
Tags:
Mindray, JHL Biotech, Amgen, Sinochem Jiangsu Pharma, Boehringer Ingelheim

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.